J Gen Virol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 72 (1991), 439-442; DOI 10.1099/0022-1317-72-2-439
© 1991 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wild, T. F.
Right arrow Articles by Buckland, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wild, T. F.
Right arrow Articles by Buckland, R.
Agricola
Right arrow Articles by Wild, T. F.
Right arrow Articles by Buckland, R.

Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion

T. F. Wild, E. Malvoisin and R. Buckland

Immunovirologie Moléculaire et Cellulaire, UMR 30/CNRS, Faculté de Médicine Alexis Carrel, 69372 Lyon Cédex 08, France

Vaccinia-measles recombinant viruses were used to examine the contribution of the individual measles virus glycoproteins in fusion. Although vaccinia virus recombinants expressing either the haemagglutinin or fusion proteins did not induce fusion in the cell lines examined, a double recombinant expressing both measles virus glycoproteins gave extensive syncytia in cells of human and simian origin. No fusion was observed in mouse, hamster or chicken cells. The fusion induced by the double recombinant could be specifically inhibited with either anti-fusion or anti-haemagglutinin monoclonal antibodies.

Received 14 September 1990; accepted 2 November 1990.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
R. W. H. Ruigrok and D. Gerlier
Structure of the measles virus H glycoprotein sheds light on an efficient vaccine
PNAS, December 26, 2007; 104(52): 20639 - 20640.
[Full Text] [PDF]


Home page
J. Virol.Home page
E. A. Corey and R. M. Iorio
Mutations in the Stalk of the Measles Virus Hemagglutinin Protein Decrease Fusion but Do Not Interfere with Virus-Specific Interaction with the Homologous Fusion Protein
J. Virol., September 15, 2007; 81(18): 9900 - 9910.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Tahara, M. Takeda, and Y. Yanagi
Altered Interaction of the Matrix Protein with the Cytoplasmic Tail of Hemagglutinin Modulates Measles Virus Growth by Affecting Virus Assembly and Cell-Cell Fusion
J. Virol., July 1, 2007; 81(13): 6827 - 6836.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
B. Sawatsky, A. Grolla, N. Kuzenko, H. Weingartl, and M. Czub
Inhibition of henipavirus infection by Nipah virus attachment glycoprotein occurs without cell-surface downregulation of ephrin-B2 or ephrin-B3
J. Gen. Virol., February 1, 2007; 88(2): 582 - 591.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Carsillo, Z. Traylor, C. Choi, S. Niewiesk, and M. Oglesbee
hsp72, a Host Determinant of Measles Virus Neurovirulence
J. Virol., November 15, 2006; 80(22): 11031 - 11039.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
K. Singethan, E. Topfstedt, S. Schubert, W. P. Duprex, B. K. Rima, and J. Schneider-Schaulies
CD9-dependent regulation of Canine distemper virus-induced cell-cell fusion segregates with the extracellular domain of the haemagglutinin
J. Gen. Virol., June 1, 2006; 87(6): 1635 - 1642.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
V. Guillaume, H. Contamin, P. Loth, I. Grosjean, M. C. G. Courbot, V. Deubel, R. Buckland, and T. F. Wild
Antibody Prophylaxis and Therapy against Nipah Virus Infection in Hamsters
J. Virol., February 15, 2006; 80(4): 1972 - 1978.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Santibanez, S. Niewiesk, A. Heider, J. Schneider-Schaulies, G. A. M. Berbers, A. Zimmermann, A. Halenius, A. Wolbert, I. Deitemeier, A. Tischer, et al.
Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
J. Gen. Virol., February 1, 2005; 86(2): 365 - 374.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Masse, M. Ainouze, B. Neel, T. F. Wild, R. Buckland, and J. P. M. Langedijk
Measles Virus (MV) Hemagglutinin: Evidence that Attachment Sites for MV Receptors SLAM and CD46 Overlap on the Globular Head
J. Virol., September 1, 2004; 78(17): 9051 - 9063.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
I. S. Novella, D. D. Reissig, and C. O. Wilke
Density-Dependent Selection in Vesicular Stomatitis Virus
J. Virol., June 1, 2004; 78(11): 5799 - 5804.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Vongpunsawad, N. Oezgun, W. Braun, and R. Cattaneo
Selectively Receptor-Blind Measles Viruses: Identification of Residues Necessary for SLAM- or CD46-Induced Fusion and Their Localization on a New Hemagglutinin Structural Model
J. Virol., January 1, 2004; 78(1): 302 - 313.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. K. Phuong, C. Allen, K.-W. Peng, C. Giannini, S. Greiner, C. J. TenEyck, P. K. Mishra, S. I. Macura, S. J. Russell, and E. C. Galanis
Use of a Vaccine Strain of Measles Virus Genetically Engineered to Produce Carcinoembryonic Antigen as a Novel Therapeutic Agent against Glioblastoma Multiforme
Cancer Res., May 15, 2003; 63(10): 2462 - 2469.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K.-W. Peng, K. A. Donovan, U. Schneider, R. Cattaneo, J. A. Lust, and S. J. Russell
Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell marker
Blood, April 1, 2003; 101(7): 2557 - 2562.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. Masse, T. Barrett, C. P. Muller, T. F. Wild, and R. Buckland
Identification of a Second Major Site for CD46 Binding in the Hemagglutinin Protein from a Laboratory Strain of Measles Virus (MV): Potential Consequences for Wild-Type MV Infection
J. Virol., December 15, 2002; 76(24): 13034 - 13038.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
S. Santibanez, A. Tischer, A. Heider, A. Siedler, and H. Hengel
Rapid replacement of endemic measles virus genotypes
J. Gen. Virol., November 1, 2002; 83(11): 2699 - 2708.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Moll, H.-D. Klenk, and A. Maisner
Importance of the Cytoplasmic Tails of the Measles Virus Glycoproteins for Fusogenic Activity and the Generation of Recombinant Measles Viruses
J. Virol., July 15, 2002; 76(14): 7174 - 7186.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Vincent, I. Tigaud, H. Schneider, C. J. Buchholz, Y. Yanagi, and D. Gerlier
Restriction of Measles Virus RNA Synthesis by a Mouse Host Cell Line: trans-Complementation by Polymerase Components or a Human Cellular Factor(s)
J. Virol., June 15, 2002; 76(12): 6121 - 6130.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
D. Christiansen, E. R. De Sousa, B. Loveland, P. Kyriakou, M. Lanteri, F. T. Wild, and D. Gerlier
A CD46CD[55-46] chimeric receptor, eight short consensus repeats long, acts as an inhibitor of both CD46 (MCP)- and CD150 (SLAM)-mediated cell-cell fusion induced by CD46-using measles virus
J. Gen. Virol., May 1, 2002; 83(5): 1147 - 1155.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
P. H. Verardi, F. H. Aziz, S. Ahmad, L. A. Jones, B. Beyene, R. N. Ngotho, H. M. Wamwayi, M. G. Yesus, B. G. Egziabher, and T. D. Yilma
Long-Term Sterilizing Immunity to Rinderpest in Cattle Vaccinated with a Recombinant Vaccinia Virus Expressing High Levels of the Fusion and Hemagglutinin Glycoproteins
J. Virol., January 15, 2002; 76(2): 484 - 491.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T. Nakayama, K. Komase, R. Uzuka, A. Hoshi, and T. Okafuji
Leucine at position 278 of the AIK-C measles virus vaccine strain fusion protein is responsible for reduced syncytium formation
J. Gen. Virol., September 1, 2001; 82(9): 2143 - 2150.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
U. Schneider, F. Bullough, S. Vongpunsawad, S. J. Russell, and R. Cattaneo
Recombinant Measles Viruses Efficiently Entering Cells through Targeted Receptors
J. Virol., November 1, 2000; 74(21): 9928 - 9936.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. C. Das, M. D. Baron, and T. Barrett
Recovery and Characterization of a Chimeric Rinderpest Virus with the Glycoproteins of Peste-des-Petits-Ruminants Virus: Homologous F and H Proteins Are Required for Virus Viability
J. Virol., October 1, 2000; 74(19): 9039 - 9047.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. P. Durbin, M. H. Skiadopoulos, J. M. McAuliffe, J. M. Riggs, S. R. Surman, P. L. Collins, and B. R. Murphy
Human Parainfluenza Virus Type 3 (PIV3) Expressing the Hemagglutinin Protein of Measles Virus Provides a Potential Method for Immunization against Measles Virus and PIV3 in Early Infancy
J. Virol., August 1, 2000; 74(15): 6821 - 6831.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. K. Plemper, A. L. Hammond, and R. Cattaneo
Characterization of a Region of the Measles Virus Hemagglutinin Sufficient for Its Dimerization
J. Virol., July 15, 2000; 74(14): 6485 - 6493.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Manchester, D. S. Eto, A. Valsamakis, P. B. Liton, R. Fernandez-Munoz, P. A. Rota, W. J. Bellini, D. N. Forthal, and M. B. A. Oldstone
Clinical Isolates of Measles Virus Use CD46 as a Cellular Receptor
J. Virol., May 1, 2000; 74(9): 3967 - 3974.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
A. Maisner, B. Mrkic, G. Herrler, M. Moll, M. A. Billeter, R. Cattaneo, and H.-D. Klenk
Recombinant measles virus requiring an exogenous protease for activation of infectivity
J. Gen. Virol., February 1, 2000; 81(2): 441 - 449.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. N. Manie, S. Debreyne, S. Vincent, and D. Gerlier
Measles Virus Structural Components Are Enriched into Lipid Raft Microdomains: a Potential Cellular Location for Virus Assembly
J. Virol., January 1, 2000; 74(1): 305 - 311.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
W. P. Duprex, I. Duffy, S. McQuaid, L. Hamill, S. L. Cosby, M. A. Billeter, J. Schneider-Schaulies, V. ter Meulen, and B. K. Rima
The H Gene of Rodent Brain-Adapted Measles Virus Confers Neurovirulence to the Edmonston Vaccine Strain
J. Virol., August 1, 1999; 73(8): 6916 - 6922.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. Takeda, A. Kato, F. Kobune, H. Sakata, Y. Li, T. Shioda, Y. Sakai, M. Asakawa, and Y. Nagai
Measles Virus Attenuation Associated with Transcriptional Impediment and a Few Amino Acid Changes in the Polymerase and Accessory Proteins
J. Virol., November 1, 1998; 72(11): 8690 - 8696.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. E. Dutch, S. B. Joshi, and R. A. Lamb
Membrane Fusion Promoted by Increasing Surface Densities of the Paramyxovirus F and HN Proteins: Comparison of Fusion Reactions Mediated by Simian Virus 5 F, Human Parainfluenza Virus Type 3 F, and Influenza Virus HA
J. Virol., October 1, 1998; 72(10): 7745 - 7753.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
T. Cathomen, H. Y. Naim, and R. Cattaneo
Measles Viruses with Altered Envelope Protein Cytoplasmic Tails Gain Cell Fusion Competence
J. Virol., February 1, 1998; 72(2): 1224 - 1234.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
I. Grosjean, C. Caux, C. Bella, I. Berger, F. Wild, J. Banchereau, and D. Kaiserlian
Measles Virus Infects Human Dendritic Cells and Blocks Their Allostimulatory Properties for CD4+ T Cells
J. Exp. Med., September 15, 1997; 186(6): 801 - 812.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Buchholz, D. Koller, P. Devaux, C. Mumenthaler, J. Schneider-Schaulies, W. Braun, D. Gerlier, and R. Cattaneo
Mapping of the Primary Binding Site of Measles Virus to Its Receptor CD46
J. Biol. Chem., August 29, 1997; 272(35): 22072 - 22079.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Iwata, T. Seya, Y. Yanagi, J. M. Pesando, P. M. Johnson, M. Okabe, S. Ueda, H. Ariga, and S. Nagasawa
Diversity of Sites for Measles Virus Binding and for Inactivation of Complement C3b and C4b on Membrane Cofactor Protein CD46
J. Biol. Chem., June 23, 1995; 270(25): 15148 - 15152.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1991 by the Society for General Microbiology.